Recent studies have highlighted differences in GPC2 transcript expression between neuroblastoma cells and normal tissues, suggesting the existence of a tumor-selective GPC2 sequence that can be targeted specifically to the tumor (72). The gene discussed is GPC2; the disease is neuroblastoma.